ArticleEngineering (Beijing, China)2020

Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment.

Jiajia Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.